Get startedLog in
    Picture of Tchaikapharma High Quality Medicines AD logo

    THQM — Tchaikapharma High Quality Medicines AD Income Statement

    0.000.00%
    bg flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Tchaikapharma High Quality Medicines AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS    		—
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue40.442.643.248.653.3
    Cost of Revenue
    Gross Profit10.411.812.41517.9
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses39.841.140.844.647.5
    Operating Profit0.5391.462.333.975.75
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes0.6241.573.133.875.62
    Provision for Income Taxes
    Net Income After Taxes0.6041.42.793.45.04
    Net Income Before Extraordinary Items
    Net Income0.6041.42.793.45.04
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income0.6041.42.793.45.04
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.0010.0010.0020.0030.055
    Dividends per Share